Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 283 of 283 entries
View as:

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04273646 Org: User:
Start: 04/20/20 End: 02/15/22 Due: 02/15/23

HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06244225 Org: User:
Start: 01/01/24 End: 01/01/28 Due: 01/01/29

High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

Phase: N/A Priority: Normal
NCT ID: NCT05585151 Org: User:
Start: 11/09/22 End: 10/01/24 Due: 10/01/25

Chest X-Ray Image Diagnosis and Report Generation Dedicated Model Based on Deepseek

Phase: N/A Priority: Normal
NCT ID: NCT06874647 Org: User:
Start: 03/10/25 End: 03/31/25 Due: 03/31/26

A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT06691685 Org: User:
Start: 11/18/24 End: 11/01/27 Due: 11/01/28

Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric

Phase: N/A Priority: Normal
NCT ID: NCT05387681 Org: User:
Start: 05/30/22 End: 12/30/25 Due: 12/30/26

Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex

Phase: N/A Priority: Normal
NCT ID: NCT05028088 Org: User:
Start: 07/01/21 End: 12/31/22 Due: 12/31/23

Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06994078 Org: User:
Start: 07/01/25 End: 04/30/26 Due: 04/30/27